Description: ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.
Home Page: www.ablbio.com
16 Daewangpangyo-Ro 712 Beon-Gil
Seongnam,
13488
South Korea
Phone:
82 31 8018 9800
Officers
| Name | Title |
|---|---|
| Dr. Sang Hoon Lee | Founder & CEO |
| Mr. Jaecheon Lee | MD & CFO |
| Jung Dae Kim | MD & COO |
| Mr. You Weon-Kyoo | Head of R&D and MD |
| Jae Ho Jung Ph.D. | MD & Head of Discovery |
| Jong Ran Kim | MD & Head of Clinical Devel. |
| Jong Hwa Won Ph.D. | Head of Early Devel. |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 101.3769 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |